MALKOX CV D/S
AMOXICILLIN 200 MG + CLAV 28.50 MG D/S
Brand: MALKOX CV D/S
MRP
₹MAX AS PER DPCO
Packaging
30 ML GLASS BOTTLE WITH WATER
Form
ANTIBIOTIC
Description & Usage
Amoxicillin 200 MG, Clav 28.50 MG D/S
Amoxicillin 200 MG, Clav 28.50 MG D/S is a pharmaceutical dry syrup that is formulated using a blend of Amoxicillin and Clavulanic Acid. This combination is a significant entity in the antibiotic dry syrup segment and is widely found on many pharma companies' portfolios. It's strength of Amoxicillin 200 mg and Clav 28.50 mg gives this product a professional standing in Pediatric and General medicine product line.
This formulation comes in the form of a dry syrup which makes it very handy as far as storage, packing, transportation and supplying through various pharma channels. It is the most apt product for those pharma businesses operating on PCD pharma franchise, third party manufacturing, branded medicine marketing, and pharmaceutical distribution etc. With standard manufacturing and excellent packing along with prompt availability, Amoxicillin 200 MG, Clav 28.50 MG D/S is an ideal addition to the professional antibiotic products line.
Composition Profile And Dry Syrup Formulation Value
Amoxicillin 200 mg and Clavulanic Acid 28.50 mg is the main composition present in the each dry syrup formulation. Whereas Amoxicillin is a known and accepted name in the antibiotic product line, Clavulanic acid enhances the strength profile of this combo formulation and makes it one of the best available combinations in the pharmaceutical segment.
The dry syrup formulation contains different pharmaceutical grade excipients, sweetening agents, suspending agents, flavoring agents and stabilizers for providing the best palatability, acceptable suspension qualities, powder flow property, storage stability, and good suspension characteristics after constitution. A dry syrup needs to contain uniform distribution of the ingredients and stable quality throughout the shelf life.
Quality Manufacturing And Processing Standards
The manufacturing of Amoxicillin 200 MG, Clav 28.50 MG D/S should take place under controlled hygienic and standard pharmaceutical manufacturing conditions where all quality standards are maintained with strict guidelines. Highly skilled and experienced pharma companies ensure good quality raw materials, advanced machinery and ideal conditions for maintaining the product quality. Every step from formulation to final packaging is supervised by technically qualified and expert personnel to attain desired standards.
Various checkpoints are applied for the product that may include raw material testing, inspection of the dry powder mixing and uniformity checks, moisture analysis, dry syrup filling, ready-to-market product analysis, bottle sealing verification and package inspections. The dry syrup formulations are sensitive towards moisture, thus it is critical that these should be maintained and packed in an extremely good way.
Good manufacturing practices assure high level of consistency for every batch that enhances its brand value to be readily accepted by the wholesalers, retailers and franchise partners. A company that is committed towards quality helps itself to earn the trust of its marketing partners thereby securing an increased market share.
Packaging, Labeling And Brand Presentation
The Amoxicillin 200 MG, Clav 28.50 MG D/S packaging should always protect its quality attributes and reflect the professional image of the brand. Bottles with tight caps are preferred with the product, packed inside attractive outer cartons. The packaging should guard the contents against moisture, air contact, pollution, accidental opening of the seal, leakage after preparation, or damage when stocked and transported.
Product label and packaging needs to have clear and legible branding, salt name, dosage strength, pack size, batch and manufacturing dates, expiry date, MRP value, and proper storing conditions. Clean, clear and well-spaced font designs improve the perception for its product, especially in a case of a quality medicine, giving it an added value.
Pharma company branding could use these well-packed medicines as strong tools to boost their brand value in the respective segment of antibiotic dry syrups. The clarity of the bottle labels, the layout of the cartons, the bold print on the compositions help one gain a step ahead over the competition, improving the value of the product.
Market Demand And Business Importance
Amoxicillin 200 MG, Clav 28.50 MG D/S finds a large demand in the pharmaceutical sector. Dry syrup formulations are a necessary part of the pediatric and general product lines. This product helps pharma companies to augment their dry syrup section with a very recognizable and required product that always generates sales and that also improves the credibility of the firm.
It has high business importance as far as wholesaler, retailer, distributors and PCD pharma franchise are concerned. Many pharma companies opt for adding this specific drug in their portfolio to ensure a complete range of antibiotic products. A pharmaceutical portfolio which includes dry syrups, tablets, capsules, oral suspensions, injections etc., would ensure a great scope and increase the coverage of business.
Quality manufacturing, fine packaging and prompt supply make the product stand as a high-potential value addition for the company, helping them achieve excellent market trust and strong relation with all channel partners. The product is an important addition for both the already settled firms and for the aspiring pharmaceutical businesses which aim to strengthen the antibiotic/pediatric sector of their brand.
PCD Pharma Franchise Scope
The scope of Amoxicillin 200 MG, Clav 28.50 MG D/S for PCD Pharma Franchise is excellent. It comes in a generally demanded section of antibiotics in dry syrup form that will be well accepted if it is advertised appropriately. The marketing companies can also provide its partners with various forms of promotional inputs such as visuals aids, product cards, prescription reminder pads, MR bags, product mockups, product literature etc to enhance its marketing efforts.
The product may offer a great range addition for franchise distributors; especially a company offering quality assurance, better packaging, monopoly marketing rights, faster supply and efficient product promotions may carve out a substantial market for itself. The formulation in itself due to its dry syrup nature, a proven combo composition and constant demand is a vital inclusion for any pharma company aiming at increasing their pharma franchise business.
Amoxicillin 200 MG, Clav 28.50 MG D/S
Amoxicillin 200 MG, Clav 28.50 MG D/S is a pharmaceutical dry syrup that is formulated using a blend of Amoxicillin and Clavulanic Acid. This combination is a significant entity in the antibiotic dry syrup segment and is widely found on many pharma companies' portfolios. It's strength of Amoxicillin 200 mg and Clav 28.50 mg gives this product a professional standing in Pediatric and General medicine product line.
This formulation comes in the form of a dry syrup which makes it very handy as far as storage, packing, transportation and supplying through various pharma channels. It is the most apt product for those pharma businesses operating on PCD pharma franchise, third party manufacturing, branded medicine marketing, and pharmaceutical distribution etc. With standard manufacturing and excellent packing along with prompt availability, Amoxicillin 200 MG, Clav 28.50 MG D/S is an ideal addition to the professional antibiotic products line.
Composition Profile And Dry Syrup Formulation Value
Amoxicillin 200 mg and Clavulanic Acid 28.50 mg is the main composition present in the each dry syrup formulation. Whereas Amoxicillin is a known and accepted name in the antibiotic product line, Clavulanic acid enhances the strength profile of this combo formulation and makes it one of the best available combinations in the pharmaceutical segment.
The dry syrup formulation contains different pharmaceutical grade excipients, sweetening agents, suspending agents, flavoring agents and stabilizers for providing the best palatability, acceptable suspension qualities, powder flow property, storage stability, and good suspension characteristics after constitution. A dry syrup needs to contain uniform distribution of the ingredients and stable quality throughout the shelf life.
Quality Manufacturing And Processing Standards
The manufacturing of Amoxicillin 200 MG, Clav 28.50 MG D/S should take place under controlled hygienic and standard pharmaceutical manufacturing conditions where all quality standards are maintained with strict guidelines. Highly skilled and experienced pharma companies ensure good quality raw materials, advanced machinery and ideal conditions for maintaining the product quality. Every step from formulation to final packaging is supervised by technically qualified and expert personnel to attain desired standards.
Various checkpoints are applied for the product that may include raw material testing, inspection of the dry powder mixing and uniformity checks, moisture analysis, dry syrup filling, ready-to-market product analysis, bottle sealing verification and package inspections. The dry syrup formulations are sensitive towards moisture, thus it is critical that these should be maintained and packed in an extremely good way.
Good manufacturing practices assure high level of consistency for every batch that enhances its brand value to be readily accepted by the wholesalers, retailers and franchise partners. A company that is committed towards quality helps itself to earn the trust of its marketing partners thereby securing an increased market share.
Packaging, Labeling And Brand Presentation
The Amoxicillin 200 MG, Clav 28.50 MG D/S packaging should always protect its quality attributes and reflect the professional image of the brand. Bottles with tight caps are preferred with the product, packed inside attractive outer cartons. The packaging should guard the contents against moisture, air contact, pollution, accidental opening of the seal, leakage after preparation, or damage when stocked and transported.
Product label and packaging needs to have clear and legible branding, salt name, dosage strength, pack size, batch and manufacturing dates, expiry date, MRP value, and proper storing conditions. Clean, clear and well-spaced font designs improve the perception for its product, especially in a case of a quality medicine, giving it an added value.
Pharma company branding could use these well-packed medicines as strong tools to boost their brand value in the respective segment of antibiotic dry syrups. The clarity of the bottle labels, the layout of the cartons, the bold print on the compositions help one gain a step ahead over the competition, improving the value of the product.
Market Demand And Business Importance
Amoxicillin 200 MG, Clav 28.50 MG D/S finds a large demand in the pharmaceutical sector. Dry syrup formulations are a necessary part of the pediatric and general product lines. This product helps pharma companies to augment their dry syrup section with a very recognizable and required product that always generates sales and that also improves the credibility of the firm.
It has high business importance as far as wholesaler, retailer, distributors and PCD pharma franchise are concerned. Many pharma companies opt for adding this specific drug in their portfolio to ensure a complete range of antibiotic products. A pharmaceutical portfolio which includes dry syrups, tablets, capsules, oral suspensions, injections etc., would ensure a great scope and increase the coverage of business.
Quality manufacturing, fine packaging and prompt supply make the product stand as a high-potential value addition for the company, helping them achieve excellent market trust and strong relation with all channel partners. The product is an important addition for both the already settled firms and for the aspiring pharmaceutical businesses which aim to strengthen the antibiotic/pediatric sector of their brand.
PCD Pharma Franchise Scope
The scope of Amoxicillin 200 MG, Clav 28.50 MG D/S for PCD Pharma Franchise is excellent. It comes in a generally demanded section of antibiotics in dry syrup form that will be well accepted if it is advertised appropriately. The marketing companies can also provide its partners with various forms of promotional inputs such as visuals aids, product cards, prescription reminder pads, MR bags, product mockups, product literature etc to enhance its marketing efforts.
The product may offer a great range addition for franchise distributors; especially a company offering quality assurance, better packaging, monopoly marketing rights, faster supply and efficient product promotions may carve out a substantial market for itself. The formulation in itself due to its dry syrup nature, a proven combo composition and constant demand is a vital inclusion for any pharma company aiming at increasing their pharma franchise business.